---
annotations:
- id: PW:0000003
  parent: signaling pathway
  type: Pathway Ontology
  value: signaling pathway
authors:
- ReactomeTeam
- Anwesha
- Ryanmiller
- Mkutmon
description: The interleukin-2 family (also called the common gamma chain cytokine
  family) consists of interleukin (IL)2, IL9, IL15 and IL21. Although sometimes considered
  to be within this family, the IL4 and IL7 receptors can form complexes with other
  receptor chains and are represented separately in Reactome. Receptors of this family
  associate with JAK1 and JAK3, primarily activating STAT5, although certain family
  members can also activate STAT1, STAT3 or STAT6.   View original pathway at [http://www.reactome.org/PathwayBrowser/#DIAGRAM=451927
  Reactome].
last-edited: 2021-01-25
organisms:
- Homo sapiens
redirect_from:
- /index.php/Pathway:WP2732
- /instance/WP2732
revision: null
schema-jsonld:
- '@context': https://schema.org/
  '@id': https://wikipathways.github.io/pathways/WP2732.html
  '@type': Dataset
  creator:
    '@type': Organization
    name: WikiPathways
  description: The interleukin-2 family (also called the common gamma chain cytokine
    family) consists of interleukin (IL)2, IL9, IL15 and IL21. Although sometimes
    considered to be within this family, the IL4 and IL7 receptors can form complexes
    with other receptor chains and are represented separately in Reactome. Receptors
    of this family associate with JAK1 and JAK3, primarily activating STAT5, although
    certain family members can also activate STAT1, STAT3 or STAT6.   View original
    pathway at [http://www.reactome.org/PathwayBrowser/#DIAGRAM=451927 Reactome].
  keywords:
  - '(p-Y694-STAT5A,p-Y699-STAT5B) '
  - 1A PI3Ks
  - ADP
  - ATP
  - 'GAB2 '
  - GRB2-1
  - 'GRB2-1 '
  - GRB2-1:SOS1
  - GRB2:GAB2
  - HAVCR2
  - 'HAVCR2 '
  - HAVCR2:LGALS9
  - 'High affinity binding complex dimers of cytokine receptors using Bc, inactive
    JAK2, p(Y593,628)- Bc:p(427,349,350)-SHC1:GRB2:GAB2 '
  - 'High affinity binding complex dimers of cytokine receptors using Bc, inactive
    JAK2, p(Y593,628)- Bc:p(427,349,350)-SHC1:GRB2:p(Y)-GAB2 '
  - 'High affinity binding complex dimers of cytokine receptors using Bc, inactive
    JAK2, p(Y593,628)- Bc:p(427,349,350)-SHC1:GRB2:p(Y)-GAB2:p85-containing Class
    1A PI3Ks '
  - 'High affinity binding complex dimers of cytokine receptors using Bc, inactive
    JAK2, p-(Y593,628)-Bc:p(427,349,350)-SHC1 '
  - IL2
  - 'IL2 '
  - IL21
  - 'IL21 '
  - IL21:IL21R:JAK1
  - IL21:IL21R:JAK1:IL2RG:JAK3
  - IL21:IL21R:p-Y-JAK1:IL2RG:p-Y-JAK3
  - IL21:IL21R:p-Y-JAK1:IL2RG:p-Y-JAK3:STAT1,STAT3,STAT4,STAT5
  - IL21:IL21R:p-Y-JAK1:IL2RG:p-Y-JAK3:p-Y701-STAT1,p-Y705-STAT3,p-Y693-STAT4,(p-Y694-STAT5A,p-Y699-STAT5B)
  - 'IL21R '
  - IL21R:JAK1
  - IL2:IL2R
  - IL2:IL2R trimer
  - IL2:IL2RA
  - IL2:IL2RA:IL2RB:JAK1
  - IL2RA
  - 'IL2RA '
  - IL2RB
  - 'IL2RB '
  - IL2RB:JAK1
  - IL2RG
  - 'IL2RG '
  - IL2RG:JAK3
  - 'INPP5D '
  - 'INPPL1 '
  - Interleukin
  - Interleukin receptor
  - Interleukin-15
  - Interleukin-9
  - JAK1
  - 'JAK1 '
  - JAK3
  - 'JAK3 '
  - JAK3 inhibitors
  - JAK3:JAK3 inhibitors
  - JAK3:PYK2
  - JAK3:p-PYK2
  - 'LCK '
  - LGALS9
  - 'LGALS9 '
  - 'PIK3CA '
  - 'PIK3CB '
  - 'PIK3CD '
  - 'PIK3R1 '
  - 'PIK3R2 '
  - 'PIK3R3 '
  - PTK2B
  - 'PTK2B '
  - 'PTPN6 '
  - RAF/MAP kinase
  - SHC kinases in IL2
  - SHC1
  - 'SHC1 '
  - SHC1:GRB2:SOS1
  - SHC1:SHIP1
  - SHC1:SHIP1,2
  - SHC1:SHIP:GRB2
  - SHIP1,2
  - 'SOS1 '
  - 'STAT1 '
  - STAT1,STAT3,STAT4,STAT5
  - 'STAT3 '
  - 'STAT4 '
  - 'STAT5 '
  - 'STAT5A '
  - STAT5A,STAT5B
  - 'STAT5B '
  - SYK
  - 'SYK '
  - Shc:GRB2:GAB2
  - Shc:GRB2:p-GAB2
  - Shc:GRB2:p-GAB2:p85-containing Class 1 PI3Ks
  - Stimulation of lymphocytes by IL15 release MAPK activation through GAB2/SHP2/SHC
    (GRB2-associated-binding protein 2/Tyrosine-protein phosphatase non-receptor type
    11/SHC transforming protein 1 or 2) cascade activation (Gadina et al. 2000).
  - There are five variants of the p85 regulatory subunit, designated p85alpha, p55alpha,
    p50alpha, p85beta, and p55gamma. There are also three variants of the p110 catalytic
    subunit designated p110alpha, beta, or gamma catalytic subunit. The first three
    regulatory subunits are all splice variants of the same gene (Pik3r1), the other
    two are expressed by Pik3r2 and Pik3r3, respectively). The most highly expressed
    regulatory subunit is p85alpha.  All three catalytic subunits are expressed by
    separate genes (Pik3ca, Pik3cb, and Pik3cd for p110alpha, p110beta and p110gamma,
    respectively). The alpha and beta p110s are expressed in all cells, while p110gamma
    is expressed primarily in leukocytes. It has been suggested that it evolved in
    parallel with the adaptive immune system. The regulatory p101 and catalytic p110gamma
    subunits comprise the class IB PI3Ks, each is encoded by a single gene.
  - Y510)
  - activated
  - activated SHC1
  - 'baricitinib '
  - beta
  - cascade
  - compexes with
  - complexes
  - complexes with
  - p-(Y338,392,510)
  - p-(Y338,392,510)-beta subunit:p-JAK1:JAK3:SHC
  - p-(Y338,392,510)-beta subunit:p-JAK1:JAK3:p-SHC
  - p-(Y338,Y392,
  - p-STAT5 dimer
  - p-STAT5A, p-STAT5B
  - 'p-Y-GAB2 '
  - 'p-Y-JAK1 '
  - 'p-Y-JAK3 '
  - 'p-Y-PTK2B '
  - 'p-Y-SHC1 '
  - 'p-Y-SYK '
  - 'p-Y364,Y418,Y536-IL2RB '
  - 'p-Y693-STAT4 '
  - 'p-Y694-STAT5A '
  - 'p-Y699-STAT5B '
  - 'p-Y701-STAT1 '
  - 'p-Y705-STAT3 '
  - p85-containing Class
  - receptor
  - signaling
  - subunit:p-JAK1:JAK3
  - subunit:p-JAK1:JAK3:STAT5
  - subunit:p-JAK1:JAK3:p-STAT5
  - trimer
  - trimer:JAK1:JAK3
  - trimer:p-JAK1:JAK3
  - trimer:p-JAK1:JAK3:SYK
  - trimer:p-JAK1:JAK3:p-SYK
  - with
  license: CC0
  name: Interleukin-2 family signaling
seo: CreativeWork
title: Interleukin-2 family signaling
wpid: WP2732
---